Biological activities of cytokine-neutralizing hyaluronic acid-antibody conjugates

Wound Repair and Regeneration

Volumn 18, Issue 3, 2010, Pages 302-310

  Sun, Liang Tso ^a   Bencherif, Sidi A ^a   Gilbert, Thomas W ^b,c   Farkas, Adam M ^b   Lotze, Michael T ^b,c   Washburn, Newell R ^a,c  

^a CARNEGIE MELLON UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BIOPOLYMER; CD163 ANTIGEN; CD68 ANTIGEN; CHEMOKINE RECEPTOR CCR7; HYALURONIC ACID ARGINYLGLYCYLASPARTIC ACID CONJUGATE; HYALURONIC ACID ARGINYLGLYCYLASPARTIC ACID INTERLEUKIN 1BETA MONOCLONAL ANTIBODY CONJUGATE; HYALURONIC ACID TUMOR NECROSIS FACTOR ALPHA MONOCLONAL ANTIBODY CONJUGATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; WOUND HEALING PROMOTING AGENT; ANTIBODY CONJUGATE; HYALURONIC ACID; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BINDING AFFINITY; BIOLOGICAL ACTIVITY; CELL ACTIVATION; CONTROLLED STUDY; COVALENT BOND; DRUG SYNTHESIS; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MOLECULAR WEIGHT; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; VISCOSITY; ANIMAL; EXTRACELLULAR MATRIX; IMMUNOLOGY; TUMOR CELL LINE; WOUND HEALING;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; CELL LINE, TUMOR; EXTRACELLULAR MATRIX; HUMANS; HYALURONIC ACID; IMMUNOCONJUGATES; IN VITRO TECHNIQUES; INFLAMMATION; INTERLEUKIN-1BETA; MONOCYTES; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA; WOUND HEALING;

EID: 77952245288     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1524-475X.2010.00591.x     Document Type: Article

References (40)

1. Lutolf MP, Hubbell JA. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol 2005 23 : 47 55.
2. Thomson AW, Lotze MT, editors. The cytokine handbook. 4th ed.
3. Hay ED, editor. Cell biology of extracellular matrix.
4. Nathan C, Sporn M. Cytokines in context. J Cell Biol 1991 113 : 981 986.
5. Gohring W, Sasaki T, Heldin CH, Timpl R. Mapping of the binding of platelet-derived growth factor to distinct domains of the basement membrane proteins BM-40 and perlecan and distinction from the BM-40 collagen-binding epitope. Eur J Biochem 1998 255 : 60 6.
6. Massague J. The transforming growth factor-beta family. Annu Rev Cell Biol 1990 6 : 597 641.
7. Mooradian DL, Lucas RC, Weatherbee JA, Furcht LT. Transforming growth factor-beta 1 binds to immobilized fibronectin. J Cell Biochem 1989 41 : 189 200.
8. Schultz GS, Wysocki A. Interactions between extracellular matrix and growth factors in wound healing. Wound Repair Regen 2009 17 : 153 162.
9. Eming SA, Krieg T, Davidson JM. Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol 2007 127 : 514 525.
10. Medina A, Scott PG, Ghahary A, Tredget EE. Pathophysiology of chronic nonhealing wounds. J Burn Care Rehabil 2005 26 : 306 319.
11. Cooper DM, Yu EZ, Hennessey P, Ko F, Robson MC. Determination of endogenous cytokines in chronic wounds. Ann Surg 1994 219 : 688, discussion 691-2.
12. Tarnuzzer RW, Schultz GS. Biochemical analysis of acute and chronic wound environments. Wound Repair Regen 1996 4 : 321 325.
13. Ramsden L, Rider CC. Selective and differential binding of interleukin (IL)-1 alpha, IL-1 beta, IL-2 and IL-6 to glycosaminoglycans. Eur J Immunol 1992 22 : 3027 3031.
14. Sahni A, Guo M, Sahni SK, Francis CW. Interleukin-1beta but not IL-1alpha binds to fibrinogen and fibrin and has enhanced activity in the bound form. Blood 2004 104 : 409 414.
15. Krause WE, Bellomo EG, Colby RH. Rheology of sodium hyaluronate under physiological conditions. Biomacromolecules 2001 2 : 65 9.
16. Steed DL, Ricotta JJ, Prendergast JJ, Kaplan RJ, Webster MW, McGill JB, Schwartz SL. Promotion and acceleration of diabetic ulcer healing by arginine-glycine-aspartic acid (RGD) peptide matrix. RGD Study Group. Diabetes Care 1995 18 : 39 46.
17. Wethers DL, Ramirez GM, Koshy M, et al. Accelerated healing of chronic sickle-cell leg ulcers treated with RGD peptide matrix. RGD Study Group. Blood 1994 84 : 1775 1779.
18. Savani RC, Cao G, Pooler PM, Zaman A, Zhou Z, DeLisser HM. Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis. J Biol Chem 2001 276 : 36770 36778.
19. Turley EA, Noble PW, Bourguignon LY. Signaling properties of hyaluronan receptors. J Biol Chem 2002 277 : 4589 4592.
20. Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, Ahrens T, Miyake K, Freudenberg M, Galanos C, Simon JC. Oligosaccharides of hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 2002 195 : 99 111.
21. Lotze MT, Deisseroth A, Rubartelli A. Damage associated molecular pattern molecules. Clin Immunol 2007 124 : 1 4.
22. Moore DL, Blackmore MG, Hu Y, Kaestner KH, Bixby JL, Lemmon VP, Goldberg JL. KLF family members regulate intrinsic axon regeneration ability. Science 2009 326 : 298 301.
23. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999 341 : 738 746.
24. Brown BN, Valentin JE, Stewart-Akers AM, McCabe GP, Badylak SF. Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component. Biomaterials 2009 30 : 1482 1491.
25. Vakkila J, DeMarco RA, Lotze MT. Imaging analysis of STAT1 and NF-kappaB translocation in dendritic cells at the single cell level. J Immunol Methods 2004 294 : 123 134.
26. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004 25 : 677 686.
27. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002 23 : 549 555.
28. Martinez FO, Gordon S, Locati M, Mantovani A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol 2006 177 : 7303 7311.
29. Badylak SF, Gilbert TW. Immune response to biologic scaffold materials. Semin Immunol 2008 20 : 109 116.
30. Zedler S, Faist E. The impact of endogenous triggers on trauma-associated inflammation. Curr Opin Crit Care 2006 12 : 595 601.
31. Laurent UB, Fraser JR, Laurent TC. An experimental technique to study the turnover of concentrated hyaluronan in the anterior chamber of the rabbit. Exp Eye Res 1988 46 : 49 58.
32. Milella E, Brescia E, Massaro C, Ramires PA, Miglietta MR, Fiori V, Aversa P. Physico-chemical properties and degradability of non-woven hyaluronan benzylic esters as tissue engineering scaffolds. Biomaterials 2002 23 : 1053 1063.
33. Roberts R, Gallagher J, Spooncer E, Allen TD, Bloomfield F, Dexter TM. Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis. Nature 1988 332 : 376 378.
34. Robson MC. Cytokine manipulation of the wound. Clin Plast Surg 2003 30 : 57 65.
35. Streit M, Beleznay Z, Braathen LR. Topical application of the tumour necrosis factor-alpha antibody infliximab improves healing of chronic wounds. Int Wound J 2006 3 : 171 179.
36. Karande P, Mitragotri S. Enhancement of transdermal drug delivery via synergistic action of chemicals. Biochim Biophys Acta 2009 1788 : 2362 2373.
37. Menter A, The status of biologic therapies in the treatment of moderate to severe psoriasis. Cutis 2009 84 : 14 24.
38. Di Padova F, Pozzi C, Tondre MJ, Tritapepe R. Selective and early increase of IL-1 inhibitors, IL-6 and cortisol after elective surgery. Clin Exp Immunol 1991 85 : 137 142.
39. Yamada J, Dana MR, Sotozono C, Kinoshita S. Local suppression of IL-1 by receptor antagonist in the rat model of corneal alkali injury. Exp Eye Res 2003 76 : 161 167.
40. Ishida Y, Kondo T, Kimura A, Matsushima K, Mukaida N. Absence of IL-1 receptor antagonist impaired wound healing along with aberrant NF-kappaB activation and a reciprocal suppression of TGF-beta signal pathway. J Immunol 2006 176 : 5598 5606.